Your browser doesn't support javascript.
loading
Antimicrobial susceptibility of Helicobacter pylori and mechanisms of clarithromycin resistance in strains isolated from patients in Uruguay
Torres-Debat, M. E; Pérez-Pérez, G; Olivares, A; Fernández, L; Raisler, K; Gonzalez, N; Stein, S; Bazet, M. C; Alallón, W; Cohen, H.
Afiliação
  • Torres-Debat, M. E; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
  • Pérez-Pérez, G; New York University School of Medicine. New York. USA
  • Olivares, A; New York University School of Medicine. New York. USA
  • Fernández, L; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
  • Raisler, K; New York University School of Medicine. New York. USA
  • Gonzalez, N; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
  • Stein, S; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
  • Bazet, M. C; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
  • Alallón, W; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
  • Cohen, H; Hospital de Clínicas. School of Medicine. Montevideo. Uruguay
Rev. esp. enferm. dig ; 101(11): 757-762, nov. 2009. ilus, tab
Artigo em Inglês | IBECS | ID: ibc-75169
Biblioteca responsável: ES1.1
Localização: BNCS
ABSTRACT
The prevalence and mechanisms of antibiotic resistance of Helicobacter pylori have not yet been investigated in Uruguay. The objective of this study was to assess the susceptibility of H. pylori to the most frequently used antibiotics and to determine the mechanism of resistance to clarithromycin. Seventy-nine isolates were obtained from gastric biopsies of 50 adult patients during two periods, 2001 and 2006. The former group enrolled the general population (GP), the latter group Afro-descendant (AD) subjects. The minimum inhibitory concentrations of clarithromycin, amoxicillin, tetracycline, metronidazole, and levofloxacin were determined using the E-test technique. Amplification was achieved through PCR and nucleic acid sequencing to detect mutations in the site of action of clarithromycin in the rRNA gene 23S. No amoxicillin or tetracycline-resistant strains were found. Clarithromycin resistance was found in 12% of the patients overall 19.4% resistance in AD patients and no resistance in the GP group. This difference was statistically significant. The highest resistance was seen with metronidazole (36%), present in similar proportions in the two groups 36.8% (GP) and 35.5% (AD). One GP patient and one AD patient had levofloxacin-resistant strains. Sequencing analysis of gene 23S rRNA showed that only mutation in position 2143 was presented in all clarithromycin-resistant strains(AU)
Assuntos
Texto completo: Disponível Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Omeprazol / Helicobacter pylori / Claritromicina Tipo de estudo: Fatores de risco Limite: Adulto / Idoso / Feminino / Humanos / Masculino País/Região como assunto: América do Sul / Uruguai Idioma: Inglês Revista: Rev. esp. enferm. dig Ano de publicação: 2009 Tipo de documento: Artigo Instituição/País de afiliação: Hospital de Clínicas/Uruguay / New York University School of Medicine/USA
Texto completo: Disponível Coleções: Bases de dados nacionais / Espanha Base de dados: IBECS Assunto principal: Omeprazol / Helicobacter pylori / Claritromicina Tipo de estudo: Fatores de risco Limite: Adulto / Idoso / Feminino / Humanos / Masculino País/Região como assunto: América do Sul / Uruguai Idioma: Inglês Revista: Rev. esp. enferm. dig Ano de publicação: 2009 Tipo de documento: Artigo Instituição/País de afiliação: Hospital de Clínicas/Uruguay / New York University School of Medicine/USA
...